Literature DB >> 30466495

Cost Analysis of Computerized Clinical Decision Support and Trainee Financial Incentive for Clostridioides difficile Testing.

Gregory R Madden1, Heather L Cox1, Melinda D Poulter2, Jason A Lyman3, Kyle B Enfield4, Costi D Sifri1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30466495      PMCID： PMC7035470          DOI： 10.1017/ice.2018.300

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  9 in total

1.  Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Authors:  Amy J Mathers; Melinda Poulter; Dawn Dirks; Joanne Carroll; Costi D Sifri; Kevin C Hazen
Journal:  Infect Control Hosp Epidemiol       Date:  2014-04       Impact factor: 3.254

2.  The economic burden of Clostridium difficile.

Authors:  S M McGlone; R R Bailey; S M Zimmer; M J Popovich; Y Tian; P Ufberg; R R Muder; B Y Lee
Journal:  Clin Microbiol Infect       Date:  2011-06-10       Impact factor: 8.067

3.  Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

Authors:  Lorraine Kyne; Mary Beth Hamel; Rajashekhar Polavaram; Ciarán P Kelly
Journal:  Clin Infect Dis       Date:  2001-12-17       Impact factor: 9.079

4.  Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population.

Authors:  Xiaoyan Song; John G Bartlett; Kathleen Speck; April Naegeli; Karen Carroll; Trish M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

5.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

6.  Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.

Authors:  Dongmu Zhang; Vimalanand S Prabhu; Stephen W Marcella
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

7.  Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.

Authors:  Kamal Desai; Swati B Gupta; Erik R Dubberke; Vimalanand S Prabhu; Chantelle Browne; T Christopher Mast
Journal:  BMC Infect Dis       Date:  2016-06-18       Impact factor: 3.090

8.  Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial Incentive.

Authors:  Gregory R Madden; Ian German Mesner; Heather L Cox; Amy J Mathers; Jason A Lyman; Costi D Sifri; Kyle B Enfield
Journal:  Infect Control Hosp Epidemiol       Date:  2018-04-12       Impact factor: 3.254

9.  Diagnostic Stewardship for Healthcare-Associated Infections: Opportunities and Challenges to Safely Reduce Test Use.

Authors:  Gregory R Madden; Robert A Weinstein; Costi D Sifri
Journal:  Infect Control Hosp Epidemiol       Date:  2018-01-14       Impact factor: 3.254
  9 in total
  2 in total

1.  The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities.

Authors:  Frances J Boly; Kimberly A Reske; Jennie H Kwon
Journal:  Curr Infect Dis Rep       Date:  2020-02-17       Impact factor: 3.725

2.  Patient Outcomes With Prevented vs Negative Clostridioides difficile Tests Using a Computerized Clinical Decision Support Tool.

Authors:  Gregory R Madden; Kyle B Enfield; Costi D Sifri
Journal:  Open Forum Infect Dis       Date:  2020-03-18       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.